RNA Clinical Trials Resources

  1. The Sponsor's Clinical Development Handbook For Gene Therapy Trials 6/21/2024

    Gene therapy has existed for decades, but the field is not as mature as it may seem. Here, the author provides essential insights and strategies for overcoming gene therapy development challenges.

  2. How To Unlock The Secret To Repeatable, Scalable Low Turnover 6/7/2024

    Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.

  3. Overview Of Endometrial Cancer: Global Clinical Trials Landscape 5/17/2024

    This FAQ delves into the latest developments in endometrial cancer treatment, highlighting innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

  4. Endometrial Cancer — Global Clinical Trial Landscape (2024) 5/17/2024

    Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.

  5. Shifting The Approach: 4 Tactics For ICH E6(R3) Implementation 4/30/2024

    In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.

  6. The Benefits Of Cas9 mRNA: Precision, Control, Cost Efficiency 4/26/2024

    Unlock the full potential of CRISPR-Cas9 gene editing with high-purity Cas9 mRNA, the emerging choice for safer and more efficient genome engineering.

  7. Global Prevalence And Clinical Trials Landscape Of AML 4/8/2024

    Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

  8. Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024) 4/8/2024

    Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.

  9. A New Era For Patient Recruitment And Retention In Rare Disease 3/15/2024

    Pharma and biotech companies prioritize innovation in areas of high and rare unmet need. Though the R&D landscape for these rare diseases can be difficult to navigate, changes are on the horizon.

  10. CRISPR Clinical Trials To Follow In 2024 And Beyond 3/13/2024

    CRISPR therapies are being developed for genetic disorders, cancer, and infectious diseases. Explore which CRISPR clinical trials are worth keeping an eye on this year.